Globus Medical Inc. (GMED)
84.50
0.57 (0.68%)
At close: Feb 18, 2025, 3:59 PM
84.83
0.38%
After-hours: Feb 18, 2025, 04:10 PM EST
undefined% (undefined)
| Bid | 84 |
| Market Cap | 11.51B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.62 |
| PE Ratio (ttm) | 136.3 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 85 |
| Volume | 586,069 |
| Avg. Volume (20D) | 1,074,635 |
| Open | 83.89 |
| Previous Close | 83.93 |
| Day's Range | 83.33 - 84.99 |
| 52-Week Range | 49.33 - 94.93 |
| Beta | undefined |
About GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,000
Stock Exchange NYSE
Ticker Symbol GMED
Website https://www.globusmedical.com
Analyst Forecast
According to 12 analyst ratings, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $94, which is an increase of 11.24% from the latest price.
Buy 75.00%
Hold 25.00%
Sell 0.00%
Next Earnings Release
Globus Medical Inc. is scheduled to release its earnings on Feb 20, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+9.43%
Globus Medical shares are trading higher after the...
Unlock content with
Pro Subscription
3 months ago
+1.15%
Globus Medical shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.
